These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The multiple mechanisms of amyloid deposition: the role of parkin. Mena MA, Rodríguez-Navarro JA, de Yébenes JG. Prion; 2009; 3(1):5-11. PubMed ID: 19270506 [Abstract] [Full Text] [Related]
4. Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications. Skovronsky DM, Lee VM, Trojanowski JQ. Annu Rev Pathol; 2006; 1():151-70. PubMed ID: 18039111 [Abstract] [Full Text] [Related]
14. Localized amyloidosis and Alzheimer's disease: the rationale for weekly long-term low dose amyloid-based fractionated radiotherapy. Bistolfi F. Neuroradiol J; 2008 Dec 17; 21(5):683-92. PubMed ID: 24257012 [Abstract] [Full Text] [Related]
15. Disentangling a Bad Reputation: Changing Perceptions of Amyloids. Wang M, Audas TE, Lee S. Trends Cell Biol; 2017 Jul 17; 27(7):465-467. PubMed ID: 28359692 [Abstract] [Full Text] [Related]
16. Amino acid sequence determinants and molecular chaperones in amyloid fibril formation. Nerelius C, Fitzen M, Johansson J. Biochem Biophys Res Commun; 2010 May 21; 396(1):2-6. PubMed ID: 20494101 [Abstract] [Full Text] [Related]
17. A Hybrid Model to Study Amyloid Cross-Toxicity. Henriquez G, Mendez L, Narayan M. ACS Chem Neurosci; 2020 Feb 05; 11(3):228-230. PubMed ID: 31920071 [Abstract] [Full Text] [Related]